REPROS THERAPEUTICS INC. Contracts & Agreements
67 Contracts & Agreements
- Business Finance (24 contracts)
- Business Operations (4)
- Human Resources (8)
- Intellectual Property (1)
- Mergers & Acquisitions (1)
- Real Estate (3)
- Uncategorized (26)
- Agreement and Plan of Merger, dated as of December 11, 2017, by and among Allergan Sales, LLC, Celestial Merger Sub, Inc. and Repros Therapeutics Inc (Filed With SEC on December 12, 2017)
- Agreement for Amendment to Series A and Series B Warrants, by and between the Company and Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B, dated as of December... (Filed With SEC on December 12, 2017)
- Agreement for Amendment to Series A and Series B Warrants, by and between the Company and Hudson Bay Master Fund Ltd, dated as of December 11, 2017 (Filed With SEC on December 12, 2017)
- Agreement for Amendment to Series A and Series B Warrants, by and between the Company and KBB Asset Management, dated as of December 11, 2017 (Filed With SEC on December 12, 2017)
- Agreement for Amendment to Series A and Series B Warrants, by and between the Company and Warberg Warrant Fund V, dated as of December 11, 2017 (Filed With SEC on December 12, 2017)
- Form of Escrow Agreement, by and among Allergan Sales, LLC, the Company and JPMorgan Chase Bank, N.A (Filed With SEC on December 12, 2017)
- SEVERANCE AGREEMENT AND GENERAL RELEASE (Filed With SEC on August 14, 2017)
- REPROS THERAPEUTICS, INC. SERIES A WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 14, 2017)
- REPROS THERAPEUTICS, INC. SERIES B WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 14, 2017)
- REPROS THERAPEUTICS, INC. PRE-FUNDED WARRANT TO PURCHASE COMMONSTOCK (Filed With SEC on August 14, 2017)
- REPROS THERAPEUTICS, INC. 2,744,125 Shares of Common Stock Series A Warrants to Purchase 3,742,500Shares of Common Stock Series B Warrants to Purchase 2,495,000Shares of Common... (Filed With SEC on May 22, 2017)
- REPROS THERAPEUTICS, INC. SERIES A WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 22, 2017)
- REPROS THERAPEUTICS, INC. SERIES B WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 22, 2017)
- REPROS THERAPEUTICS, INC. PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 22, 2017)
- REPROS THERAPEUTICS INC. $10,000,000 of Common Stock ($0.001 par value per share) Equity Distribution Agreement (Filed With SEC on August 9, 2016)
- THIRD AMENDMENT TO LEASE AGREEMENT (Filed With SEC on August 10, 2015)
- REPROS THERAPEUTICS INC. (a Delaware corporation) 3,750,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 24, 2013)
- PUBLIC HEALTH. SERVICE EIGHTH AMENDMENT TO L ###-###-####/0 (Filed With SEC on June 17, 2013)
- NATIONAL INSTITUTES OF HEALTH NINTH AMENDMENT TO L ###-###-####/0 (Filed With SEC on June 17, 2013)
- EMPLOYMENT AGREEMENT (Filed With SEC on April 1, 2013)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on September 12, 2012)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 12, 2012)
- 740 Broadway / 9th Floor / NewYork, NY 10003 Phone / 646 ###-###-#### Fax / 646 ###-###-#### www.troutcapital.com (Filed With SEC on September 12, 2012)
- PLACEMENT AGENCY AGREEMENT (Filed With SEC on January 27, 2012)
- SUBSCRIPTION AGREEMENT REPROS THERAPEUTICS INC. FOR UP TO 2,463,538 SHARES OF COMMONSTOCK (Filed With SEC on January 27, 2012)
- FIFTH AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on January 4, 2012)
- REPROS THERAPEUTICS INC. 2011 EQUITY INCENTIVE PLAN (Filed With SEC on March 4, 2011)
- 690,000Units REPROSTHERAPEUTICS INC. Each Unit consisting of 4 Sharesof Common Stock and 3 SeriesA Warrants and 2.45 Series B Warrants UNDERWRITINGAGREEMENT (Filed With SEC on February 9, 2011)
- SERIES A WARRANTAGREEMENT (Filed With SEC on February 9, 2011)
- SERIES B WARRANTAGREEMENT (Filed With SEC on February 9, 2011)
- Exhibit1.1 []Units REPROSTHERAPEUTICS INC. Each Unit consisting of []Shares of Common Stock and []Series A Warrants and [] Series BWarrants UNDERWRITINGAGREEMENT (Filed With SEC on February 2, 2011)
- Company (Filed With SEC on February 2, 2011)
- Company and ComputershareTrust Company, N.A., WarrantAgent (Filed With SEC on February 2, 2011)
- SECOND AMENDMENT TOLEASE (Filed With SEC on November 10, 2010)
- SIXTHAMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on September 10, 2010)
- FOURTHAMENDMENT TO EMPLOYMENTAGREEMENT (Filed With SEC on March 11, 2010)
- REPROSTHERAPEUTICS INC. $10,000,000of Common Stock ($0.001par value per share) Equity DistributionAgreement (Filed With SEC on February 19, 2010)
- ConfidentialTreatment Requested PUBLICHEALTH SERVICE SIXTH AMENDMENT TOL ###-###-####/0 (Filed With SEC on December 22, 2009)
- MASTER SETTLEMENT AGREEMENTAND RELEASES (Filed With SEC on November 3, 2009)
- Repros TherapeuticsInc. ConsultingAgreement (Filed With SEC on November 3, 2009)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on October 14, 2009)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on September 10, 2009)
- ConfidentialTreatment Requested PUBLIC HEALTH SERVICE (Filed With SEC on July 10, 2009)
- INDEMNIFICATION AGREEMENT (Filed With SEC on May 20, 2009)
- THIRD AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on March 17, 2009)
- EMPLOYMENT AGREEMENT (Filed With SEC on February 24, 2009)
- FIFTH AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on October 10, 2008)
- SECOND AMENDMENT TO STANDSTILL AGREEMENT (Filed With SEC on October 3, 2008)
- AMENDED AND RESTATED COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on October 3, 2008)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on September 29, 2008)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on September 29, 2008)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on September 29, 2008)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on September 29, 2008)
- FIRST AMENDMENT TO STANDSTILL AGREEMENT (Filed With SEC on July 28, 2008)
- FOURTH AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on January 10, 2008)
- STANDSTILL AGREEMENT (Filed With SEC on January 10, 2008)
- L-354-98/4 FOURTH AMENDMENT TO PATENT LICENSE AGREEMENT (Filed With SEC on March 20, 2007)
- [LETTERHEAD FOR NIH OFFICE OF TECHNOLOGY TRANSFER] March 8, 2007 (Filed With SEC on March 20, 2007)
- CONFIDENTIAL TREATMENT REQUESTED PUBLIC HEALTH SERVICE FIFTH AMENDMENT TO L ###-###-####/0 (Filed With SEC on March 20, 2007)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 8, 2007)
- Underwriting Agreement (Filed With SEC on January 31, 2007)
- Amendment to Lease dated March 17, 2006 (Filed With SEC on May 1, 2006)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on December 23, 2005)
- Third Amendment to Rights Agreement (Filed With SEC on June 30, 2005)
- Lease Agreement (Filed With SEC on March 30, 2005)
- 4,000,000 ZONAGEN, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 24, 2005)
- ZONAGEN, INC. 2004 STOCK OPTION PLAN (Filed With SEC on January 24, 2005)
